Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Continuing Education
Free online courses for addiction counselors LEARN ONLINE
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 

OxyContin Maker to Pay States Over Marketing Practices
May 10, 2007

Share Share Email
Email
Print
Print
SubscribeSubscribe
News Summary

Purdue Pharma, the maker of the painkiller OxyContin, will pay a group of states $19.5 million to settle a complaint about the marketing of the drug, the Associated Press reported May 9.

Twenty six states and the District of Columbia will share in the payment. The complaint from state attorneys general centered on Purdue's practice of encouraging doctors to prescribe OxyContin to be taken every eight hours, rather than every 12 hours as approved by the FDA.

"We're raising the bar on off-label marketing and other promotion tactics that lead to abuse and diversion of prescription drugs," said Connecticut Attorney General Richard Blumenthal. "Our combined state legal campaign will stop this manufacturer from promoting a powerful drug for inappropriate uses."

Blumenthal said the payout also settled complaints that Purdue failed to adequately warn the public about the abuse potential of OxyContin. 

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (read guidelines):

Name:

Comment:
(limit 200
words)

Enter this word
(help):
Change

GUIDELINES: 
To keep this feature useful for all, please:

  1. Keep it clean, courteous, and on-topic. Comments are meant for thoughtful discussion of the article published above.

  2. Do not post promotional links to organizations, products or services, or personal requests for assistance (get help).

  3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercially-motivated posts are prohibited. We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.